Skip to content

Zymeworks ZYME Convertible Preferred Stock Issued Shares

Convertible Preferred Stock Issued Shares at other companies

Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
0
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
0
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
0
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
0
Charles River Laboratories logo
Charles River LaboratoriesCRL
Summit Therapeutics logo
Summit TherapeuticsSMMT

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.76B+125%
Enterprise value$1.53B+112%
P/S21.6×+13.2×

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesIssued.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's convertible preferred stock issued shares.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's convertible preferred stock issued shares?
Zymeworks (ZYME) reported convertible preferred stock issued shares of 1 in Q1 2026.
How has Zymeworks's convertible preferred stock issued shares changed year-over-year?
Zymeworks's convertible preferred stock issued shares decreased by 0.0% year-over-year, from 1 to 1.
What does convertible preferred stock issued shares mean?
Number of convertible preferred shares that have been issued, whether held by investors or in treasury.